(Q36694623)

English

In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma

scientific article published on February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

F Donskov

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

N Marcussen

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Hokland

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R Fisker

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

H H T Madsen

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

H von der Maase

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

90

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

626-631

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Histamine in cancer immunotherapy: a preclinical background.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Interferon-alpha in tumor immunity and immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Progress in human tumour immunology and immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Contemporary approach to the classification of renal epithelial tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Systemic therapy for renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

30 September 2017

How does interferon exert its cell growth inhibitory effect?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

28 June 2018

Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

28 June 2018

Role of histamine in natural killer cell-mediated resistance against tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

28 June 2018

The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

28 June 2018

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

5 September 2018

Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue s

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409612

5 September 2018

Immunotherapy of renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of ploidy and proliferation markers in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of Ki-67 expression in renal cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of angiogenesis, proliferation and apoptosis in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the number of treatment courses on the clinical response of patients who receive high-dose bolus interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrasound-guided core biopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/14760375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6601587

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36694623&oldid=2199197309"